250 related articles for article (PubMed ID: 10772876)
1. Hematologically important mutations: red cell pyruvate kinase (Third update).
Bianchi P; Zanella A
Blood Cells Mol Dis; 2000 Feb; 26(1):47-53. PubMed ID: 10772876
[No Abstract] [Full Text] [Related]
2. Hematologically important mutations: red cell pyruvate kinase (2nd update).
Baronciani L; Bianchi P; Zanella A
Blood Cells Mol Dis; 1998 Sep; 24(3):273-9. PubMed ID: 10087985
[No Abstract] [Full Text] [Related]
3. Eight novel mutations and consequences on mRNA and protein level in pyruvate kinase-deficient patients with nonspherocytic hemolytic anemia.
Kugler W; Willaschek C; Holtz C; Ohlenbusch A; Laspe P; Krügener R; Muirhead H; Schröter W; Lakomek M
Hum Mutat; 2000; 15(3):261-72. PubMed ID: 10679942
[TBL] [Abstract][Full Text] [Related]
4. G-->T transition at cDNA nt 110 (K37Q) in the PKLR (pyruvate kinase) gene is the molecular basis of a case of hereditary increase of red blood cell ATP.
Beutler E; Westwood B; van Zwieten R; Roos D
Hum Mutat; 1997; 9(3):282-5. PubMed ID: 9090535
[No Abstract] [Full Text] [Related]
5. Clinical and biochemical studies on mutant red cell enzymes mainly associated with hemolytic anemia.
Miwa S
Jinrui Idengaku Zasshi; 1980 Jun; 25(2):83-92. PubMed ID: 7431680
[No Abstract] [Full Text] [Related]
6. Co-existence of hereditary spherocytosis and a new red cell pyruvate kinase variant: PK mallorca.
Zarza R; Moscardó M; Alvarez R; García J; Morey M; Pujades A; Vives-Corrons JL
Haematologica; 2000 Mar; 85(3):227-32. PubMed ID: 10702808
[TBL] [Abstract][Full Text] [Related]
7. Pyruvate kinase deficiency.
Miwa S
Nihon Ketsueki Gakkai Zasshi; 1987 Dec; 50(8):1445-52. PubMed ID: 3328943
[No Abstract] [Full Text] [Related]
8. Hematologically important mutations: red cell pyruvate kinase.
Baronciani L; Bianchi P; Zanella A
Blood Cells Mol Dis; 1996; 22(1):85-9. PubMed ID: 8807089
[No Abstract] [Full Text] [Related]
9. [From gene to disease; hereditary non-spherocytic hemolytic anemia caused by pyruvate kinase deficiency].
de Vooght KM; van Wijk R; Nieuwenhuis HK; Ploos van Amstel JK; Rijksen G; van Solinge WW
Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1828-31. PubMed ID: 12382367
[TBL] [Abstract][Full Text] [Related]
10. Human erythrocyte pyruvate kinase: characterization of the recombinant enzyme and a mutant form (R510Q) causing nonspherocytic hemolytic anemia.
Wang C; Chiarelli LR; Bianchi P; Abraham DJ; Galizzi A; Mattevi A; Zanella A; Valentini G
Blood; 2001 Nov; 98(10):3113-20. PubMed ID: 11698298
[TBL] [Abstract][Full Text] [Related]
11. [Electrophoretic heterogeneity of pyruvate kinase in erythrocytes in patients with enzymopathies].
Rotrekl B
Acta Univ Palacki Olomuc Fac Med; 1985; 111():467-73. PubMed ID: 2949531
[No Abstract] [Full Text] [Related]
12. Red cell pyruvate kinase deficiency: molecular and clinical aspects.
Zanella A; Fermo E; Bianchi P; Valentini G
Br J Haematol; 2005 Jul; 130(1):11-25. PubMed ID: 15982340
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterisation of pyruvate kinase deficiency--concerns about the description of mutant PKLR alleles.
van Wijk R; Rijksen G; van Solinge WW
Br J Haematol; 2007 Jan; 136(1):167-9; author reply 169-70. PubMed ID: 17222205
[No Abstract] [Full Text] [Related]
14. Red blood cell PK deficiency: An update of PK-LR gene mutation database.
Canu G; De Bonis M; Minucci A; Capoluongo E
Blood Cells Mol Dis; 2016 Mar; 57():100-9. PubMed ID: 26832193
[TBL] [Abstract][Full Text] [Related]
15. Pyruvate kinase "Göttingen 1,2": congenital hemolytic anemia, evidence of double heterozygosity, and lack of enzyme cooperativity.
Schröter W; Lakomek M; Scharnetzky M; Tillmann W; Winkler H
Hum Genet; 1982; 60(4):381-6. PubMed ID: 7106777
[No Abstract] [Full Text] [Related]
16. Mining for allosteric information: natural mutations and positional sequence conservation in pyruvate kinase.
Pendergrass DC; Williams R; Blair JB; Fenton AW
IUBMB Life; 2006 Jan; 58(1):31-8. PubMed ID: 16540430
[TBL] [Abstract][Full Text] [Related]
17. Fifteen novel mutations in PKLR associated with pyruvate kinase (PK) deficiency: structural implications of amino acid substitutions in PK.
van Wijk R; Huizinga EG; van Wesel AC; van Oirschot BA; Hadders MA; van Solinge WW
Hum Mutat; 2009 Mar; 30(3):446-53. PubMed ID: 19085939
[TBL] [Abstract][Full Text] [Related]
18. [Physico-chemical and kinetic properties of pyruvate kinase in erythrocytes in enzymopathic hemolytic anemia].
Rotrekl B; Wiedermann B; Mlcochová E; Prokopová M
Vnitr Lek; 1984 Jun; 30(6):542-9. PubMed ID: 6474860
[No Abstract] [Full Text] [Related]
19. Hemolytic anemia associated with a novel heterozygote mutation 1183A in the PK-LR gene (PK- Jordan).
Karadsheh NS; Gelbart T; Naffa RG
Int J Lab Hematol; 2014 Aug; 36(4):e66-8. PubMed ID: 24330591
[No Abstract] [Full Text] [Related]
20. First-trimester prenatal diagnosis of pyruvate kinase deficiency in an Indian family with the pyruvate kinase-Amish mutation.
Kedar PS; Nampoothiri S; Sreedhar S; Ghosh K; Shimizu K; Kanno H; Colah RB
Genet Mol Res; 2007 Jun; 6(2):470-5. PubMed ID: 17952871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
